Evaluating the Influence of Diabetes Stigma on Medication Adherence

CompletedOBSERVATIONAL
Enrollment

508

Participants

Timeline

Start Date

July 8, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Diabetes Mellitus
Interventions
OTHER

Comprehensive Diabetes Stigma Survey

"The surveys to be administered in the ENDSTIGMA study are as follows:~1. The Adherence to Refills and Medications for Diabetes survey is a validated, diabetes-specific survey measure utilizing patient self-report to assess diabetes medication adherence.~2. The Demographics survey will be used to assess participant baseline characteristics, including body mass index (BMI). The questions contained in this survey have been validated by Dr. Kerri Cavanaugh's research group.~3. Comprehensive Diabetes Stigma Survey is a novel survey being developed and validated in the ENDSTIGMA study. The ENDSTIGMA study will also compare the results from this survey with the medication adherence results, to determine if there is an association between diabetes stigma and medication adherence."

Trial Locations (1)

37232-2372

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT02828995 - Evaluating the Influence of Diabetes Stigma on Medication Adherence | Biotech Hunter | Biotech Hunter